These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33536995)

  • 1. Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines.
    Trevisiol C; Cani I; Fabricio ASC; Gion M; Giometto B; De Massis P
    Front Neurol; 2020; 11():607553. PubMed ID: 33536995
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
    Graus F
    Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
    Li L; Guo Y; Wang J
    Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic neurologic syndromes in children: a review article.
    Alavi S
    Iran J Child Neurol; 2013; 7(3):6-14. PubMed ID: 24665300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.
    Graus F; Vogrig A; Muñiz-Castrillo S; Antoine JG; Desestret V; Dubey D; Giometto B; Irani SR; Joubert B; Leypoldt F; McKeon A; Prüss H; Psimaras D; Thomas L; Titulaer MJ; Vedeler CA; Verschuuren JJ; Dalmau J; Honnorat J
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34006622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic neurologic syndrome: A practical approach.
    Kannoth S
    Ann Indian Acad Neurol; 2012 Jan; 15(1):6-12. PubMed ID: 22412264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.
    Michalak S; Kalinowska-Lyszczarz A; Rybacka-Mossakowska J; Zaborowski M; Kozubski W
    J Neural Transm (Vienna); 2019 Feb; 126(2):149-158. PubMed ID: 30374596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?
    Parillo M; Quattrocchi CC; Pilato F; Di Lazzaro V; Beomonte Zobel B
    Radiography (Lond); 2023 Jan; 29(1):8-13. PubMed ID: 36179410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
    Raspotnig M; Vedeler CA; Storstein A
    Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
    Chatterjee M; Hurley LC; Tainsky MA
    Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended diagnostic criteria for paraneoplastic neurological syndromes.
    Graus F; Delattre JY; Antoine JC; Dalmau J; Giometto B; Grisold W; Honnorat J; Smitt PS; Vedeler Ch; Verschuuren JJ; Vincent A; Voltz R
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1135-40. PubMed ID: 15258215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 40 years of autoantibody research in paraneoplastic neurological syndromes.
    Graus F
    Rev Neurol (Paris); 2024 Nov; 180(9):848-861. PubMed ID: 39289137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological paraneoplastic syndromes in lung cancer patients.
    Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
    Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
    Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.